Verici Dx, a company developing advanced clinical diagnostics for organ transplant, has entered into a global licensing partnership with healthcare giant Thermo Fisher to develop an assay for pre-transplant kidney testing.
Verici Dx PLC shares jumped on Wednesday after it signed an exclusive global licensing agreement with Thermo Fisher Scientific Inc to further develop an assay for pre-transplant prognostic testing for.
Agreement grants rights to further develop an assay for pre-transplant prognostic testing. CARDIFF, U.K. , November 15, 2023 / B3C newswire / Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced that it has signed an exclusive global licensing agreement wit.
Verici DX Plc Reaches a Global Licensing and Commercialisation Agreement with Thermo Fisher Scientific Agreement grants rights to further develop an assay for pre-transplant prognostic testing. CARDIFF, U.K. , November 15, 2023 / B3C newswire / Verici Dx plc (AIM: VRCI), a developer o.
Nearly one million people in the United States are living with Parkinson's disease, making it the second-most common neurodegenerative disease after Alzheimer's.